{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:21:00Z","timestamp":1791418860684,"version":"4.3.3"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.biopha.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T16:04:49Z","timestamp":1457971489000},"page":"30-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"special_numbering":"C","title":["Utilization of nanoparticle technology in rheumatoid arthritis treatment"],"prefix":"10.1016","volume":"80","author":[{"given":"Sanam","family":"Dolati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Sadreddini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davoud","family":"Rostamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Jadidi-Niaragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.03.004_bib0005","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s12272-011-1109-9","article-title":"Designing micro-and nano-particles for treating rheumatoid arthritis","volume":"34","author":"Mitragotri","year":"2011","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.biopha.2016.03.004_bib0010","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1089\/jir.2011.0056","article-title":"Collagen-induced arthritis as an animal model for rheumatoid arthritis: focus on interferon","volume":"31","author":"Schurgers","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.biopha.2016.03.004_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2014.01.027","article-title":"Diagnosis and classification of rheumatoid arthritis","volume":"48","author":"Kourilovitch","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2016.03.004_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/14397595.2013.854056","article-title":"The role of leukotrienes in immunopathogenesis of rheumatoid arthritis","volume":"24","author":"Yousefi","year":"2014","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrrheum.2012.237","article-title":"Genetics and epigenetics of rheumatoid arthritis","volume":"9","author":"Viatte","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0030","series-title":"Epigenetic Epidemiology of Inflammation and Rheumatoid Arthritis","first-page":"289","author":"Ospelt","year":"2012"},{"key":"10.1016\/j.biopha.2016.03.004_bib0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/wnan.157","article-title":"Nanotherapeutic approaches for the treatment of rheumatoid arthritis","volume":"3","author":"Pham","year":"2011","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0040","series-title":"Development of Multifunctional Nanoparticles for Targeted Therapy and Imaging of Rheumatoid Arthritis: Faculty of Engineering","author":"da Costa Moura","year":"2013"},{"key":"10.1016\/j.biopha.2016.03.004_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cyto.2015.02.002","article-title":"The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis","volume":"74","author":"Paulissen","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2016.03.004_bib0050","first-page":"5407","article-title":"Molecular targets in arthritis and recent trends in nanotherapy","volume":"10","author":"Roy","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2016.03.004_bib0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jb\/mvt049","article-title":"Immunology and bone","volume":"154","author":"Danks","year":"2013","journal-title":"J. Biochem."},{"key":"10.1016\/j.biopha.2016.03.004_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2009.02.002","article-title":"Angiogenesis and its targeting in rheumatoid arthritis","volume":"51","author":"Szekanecz","year":"2009","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/BOR.0b013e328337c95a","article-title":"Angiogenesis and vasculogenesis in rheumatoid arthritis","volume":"22","author":"Szekanecz","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0070","doi-asserted-by":"crossref","first-page":"8632","DOI":"10.1016\/j.biomaterials.2012.08.005","article-title":"Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles","volume":"33","author":"Zhou","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2016.03.004_bib0075","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/annrheumdis-2012-201978","article-title":"Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2","volume":"72","author":"Gao","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2016.03.004_bib0080","article-title":"Notch signaling mediates TNF-\u03b1-induced IL-6 production in cultured fibroblast-like synoviocytes from rheumatoid arthritis","volume":"2012","author":"Jiao","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0085","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/art.34397","article-title":"Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis","volume":"64","author":"Gao","year":"2012","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.biopha.2016.03.004_bib0090","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbrc.2014.07.085","article-title":"Genetic basis of rheumatoid arthritis: a current review","volume":"452","author":"Kochi","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2016.03.004_bib0095","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1126\/science.1195568","article-title":"Has the microbiota played a critical role in the evolution of the adaptive immune system?","volume":"330","author":"Lee","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.biopha.2016.03.004_bib0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/BOR.0b013e32832a2e16","article-title":"Environmental influences on risk for rheumatoid arthritis","volume":"21","author":"Liao","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti\u2013cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biopha.2016.03.004_bib0110","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1186\/ar3546","article-title":"Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study","volume":"13","author":"Yukawa","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2016.03.004_bib0115","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/rheumatology\/kem257","article-title":"Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis","volume":"47","author":"Emery","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2016.03.004_bib0120","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/art.20568","article-title":"Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial","volume":"50","author":"St clair","year":"2004","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.biopha.2016.03.004_bib0125","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1084\/jem.146.3.857","article-title":"Autoimmunity to type II collagen an experimental model of arthritis","volume":"146","author":"Trentham","year":"1977","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2016.03.004_bib0130","series-title":"The Development of Targeted Drug Delivery Systems for Rheumatoid Arthritis Treatment","author":"Bader","year":"2012"},{"key":"10.1016\/j.biopha.2016.03.004_bib0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.biopha.2016.03.004_bib0140","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrrheum.2010.179","article-title":"Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis","volume":"6","author":"Hoes","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrrheum.2009.182","article-title":"Treatment of rheumatoid arthritis: state of the art","volume":"5","author":"von Vollenohower","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0150","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/ard.2010.134684","article-title":"State-of-the-art rheumatoid arthritis","volume":"69","author":"McInnes","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2016.03.004_bib0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.autrev.2009.03.010","article-title":"Prospective new biological therapies for rheumatoid arthritis","volume":"9","author":"\u0160enolt","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2016.03.004_bib0160","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2217\/imt.13.94","article-title":"Current immunotherapy in rheumatoid arthritis","volume":"5","author":"Meier","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.biopha.2016.03.004_bib0165","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/ard.2010.132134","article-title":"Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis","volume":"70","author":"Salliot","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2016.03.004_bib0170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.berh.2010.02.001","article-title":"Prospects for gene therapy in inflammatory arthritis","volume":"24","author":"Jorgensen","year":"2010","journal-title":"Best Practice Res. Clin. Rheumatol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10709-009-9372-0","article-title":"Nanotechnology approaches for gene transfer","volume":"137","author":"Lundin","year":"2009","journal-title":"Genetica"},{"key":"10.1016\/j.biopha.2016.03.004_bib0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nano.2011.05.016","article-title":"Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging","volume":"8","author":"Parveen","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.biopha.2016.03.004_bib0185","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1100\/tsw.2011.106","article-title":"Nanoparticles and inflammation","volume":"11","author":"Stevenson","year":"2011","journal-title":"Sci. World J."},{"key":"10.1016\/j.biopha.2016.03.004_bib0190","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jconrel.2014.03.050","article-title":"Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles","volume":"190","author":"Anselmo","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2016.03.004_bib0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1039\/c3ib40165k","article-title":"Nanoparticles and their applications in cell and molecular biology","volume":"6","author":"Wang","year":"2014","journal-title":"Integr. Biol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2217\/nnm.10.7","article-title":"Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson\u2019s disease","volume":"5","author":"Brynskikh","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2016.03.004_bib0205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2016.03.004_bib0210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0031-6865(00)00023-6","article-title":"Long-circulating liposomes of indomethacin in arthritic rats\u2014a biodisposition study","volume":"74","author":"Srinath","year":"2000","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.biopha.2016.03.004_bib0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijpharm.2004.11.017","article-title":"Biodisposition of PEG-coated lipid microspheres of indomethacin in arthritic rats","volume":"290","author":"Palakurthi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2016.03.004_bib0220","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1476-5381.2009.00244.x","article-title":"Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats","volume":"158","author":"Bernardi","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0225","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.11140","article-title":"Complete remission of experimental arthritis by joint targeting of glucocorticoids with long\u2010circulating liposomes","volume":"48","author":"Metselaar","year":"2003","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.biopha.2016.03.004_bib0230","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s11095-010-0330-4","article-title":"Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis","volume":"28","author":"Koo","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2016.03.004_bib0235","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/art.21876","article-title":"Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor \u03b1 in experimental arthritis","volume":"54","author":"Khoury","year":"2006","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.biopha.2016.03.004_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","article-title":"Micellar nanocarriers: pharmaceutical perspectives","volume":"24","author":"Torchilin","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2016.03.004_bib0245","series-title":"What is Cancer Nanotechnology?","author":"Grobmyer","year":"2010"},{"key":"10.1016\/j.biopha.2016.03.004_bib0250","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1021\/cr900174j","article-title":"Dendrimers as carriers for delivery of chemotherapeutic agents","volume":"109","author":"Medina","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2016.03.004_bib0255","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/jpet.108.150276","article-title":"Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate","volume":"329","author":"Ishihara","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2016.03.004_bib0260","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2009.10.025","article-title":"Preparation and characterization of a nanoparticulate formulation composed of PEG-PLA and PLA as anti-inflammatory agents","volume":"385","author":"Ishihara","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2016.03.004_bib0265","first-page":"359","article-title":"\u03b1-Methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy","volume":"3","author":"Hwang","year":"2008","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2016.03.004_bib0270","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1248\/bpb.b13-00917","article-title":"Effect of solid nanoparticle of indomethacin on therapy for rheumatoid arthritis in adjuvant-Induced arthritis rat","volume":"37","author":"Nagai","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2016.03.004_bib0275","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5650\/jos.ess14170","article-title":"Topical therapies for rheumatoid arthritis by gel ointments containing indomethacin nanoparticles in adjuvant-Induced arthritis rat","volume":"64","author":"Nagai","year":"2015","journal-title":"J. Oleo. Sci."},{"key":"10.1016\/j.biopha.2016.03.004_bib0280","article-title":"Folate-targeted nanoparticles for rheumatoid arthritis therapy","author":"Nogueira","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.biopha.2016.03.004_bib0285","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1002\/art.30459","article-title":"Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis","volume":"63","author":"Thomas","year":"2011","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.biopha.2016.03.004_bib0290","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","article-title":"Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases","volume":"41","author":"Aggarwal","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0295","unstructured":"A.K. Dewangan, S. Varkey, S., Mazumder Synthesis of Curcumin Loaded CMCAB Nanoparticles for Treatment of Rheumatoid Arthritis."},{"key":"10.1016\/j.biopha.2016.03.004_bib0300","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ejp.620","article-title":"Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats","volume":"19","author":"Arora","year":"2015","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.biopha.2016.03.004_bib0305","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijpharm.2007.10.014","article-title":"Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis","volume":"352","author":"Ye","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2016.03.004_bib0310","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/nn301215q","article-title":"Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles","volume":"7","author":"Lee","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2016.03.004_bib0315","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2217\/nnm.11.90","article-title":"Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model","volume":"6","author":"Scheinman","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2016.03.004_bib0320","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/art.10198","article-title":"Suppression of collagen-induced arthritis by single administration of poly (lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance","volume":"46","author":"Kim","year":"2002","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.biopha.2016.03.004_bib0325","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2005.03.009","article-title":"Preparation and characterization of biodegradable nanoparticles entrapping immunodominant peptide conjugated with PEG for oral tolerance induction","volume":"105","author":"Lee","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2016.03.004_bib0330","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12325-010-0010-0","article-title":"PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases","volume":"27","author":"Runnels","year":"2010","journal-title":"Adv. Ther."},{"key":"10.1016\/j.biopha.2016.03.004_bib0335","article-title":"Inhibition of Notch signalling ameliorates experimental inflammatory arthritis","author":"Park","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2016.03.004_bib0340","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jconrel.2014.07.057","article-title":"Hyaluronan nanoparticles bearing \u03b3-secretase inhibitor: in vivo therapeutic effects on rheumatoid arthritis","volume":"192","author":"Heo","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2016.03.004_bib0345","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1096\/fj.09-129874","article-title":"Pham CT. \u03b1v\u03b23-Targeted nanotherapy suppresses inflammatory arthritis in mice","volume":"23","author":"Zhou","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2016.03.004_bib0350","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1182\/blood-2011-04-350173","article-title":"Methionine aminopeptidase 2 is required for HSC initiation and proliferation","volume":"118","author":"Ma","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2016.03.004_bib0355","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2217\/nnm.10.78","article-title":"Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis","volume":"5","author":"Zhou","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2016.03.004_bib0360","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/DDDT.S99651","article-title":"Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery","volume":"10","author":"Ahmed","year":"2016","journal-title":"Drug Design, Dev. Ther."},{"key":"10.1016\/j.biopha.2016.03.004_bib0365","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.actbio.2010.01.025","article-title":"New generation of chitosan-encapsulated ZnO quantum dots loaded with drug: synthesis: characterization and in vitro drug delivery response","volume":"6","author":"Yuan","year":"2010","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2016.03.004_bib0370","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.biomaterials.2005.09.020","article-title":"Characterization of folate-chitosan-DNA nanoparticles for gene therapy","volume":"27","author":"Mansouri","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2016.03.004_bib0375","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ijbiomac.2014.10.052","article-title":"Chitosan-based nanoparticles for tumor-targeted drug delivery","volume":"72","author":"Prabaharan","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0380","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2015.08.025","article-title":"Notch1 targeting siRNA delivery nanoparticles for rheumatoid arthritis therapy","volume":"216","author":"Kim","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2016.03.004_bib0385","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/mt.2013.245","article-title":"TNF-\u03b1 gene silencing using polymerized siRNA\/thiolated glycol chitosan nanoparticles for rheumatoid arthritis","volume":"22","author":"Lee","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2016.03.004_bib0390","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/mt.2008.99","article-title":"Bone-protective effects of nonviral gene therapy with Folate\u2013Chitosan DNA nanoparticle containing Interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis","volume":"16","author":"Fernandes","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2016.03.004_bib0395","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/art.30174","article-title":"Cytosolic phospholipase A2\u03b1 gene silencing in the myeloid lineage alters development of Th1 responses and reduces disease severity in collagen-induced arthritis","volume":"63","author":"Courties","year":"2011","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.biopha.2016.03.004_bib0400","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1016\/j.biomaterials.2014.04.109","article-title":"The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis","volume":"35","author":"Samarasinghe","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2016.03.004_bib0405","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"Pr\u00e9at V.PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2016.03.004_bib0410","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1125949","article-title":"Molecular imaging in cancer","volume":"312","author":"Weissleder","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.biopha.2016.03.004_bib0415","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s003300100908","article-title":"Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging","volume":"11","author":"Wang","year":"2001","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0420","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nm1101-1241","article-title":"Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent","volume":"7","author":"Zhao","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2016.03.004_bib0425","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/ar2572","article-title":"Tissue engineering in the rheumatic diseases","volume":"11","author":"Ringe","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2016.03.004_bib0430","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/rheumatology\/kep162","article-title":"Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit","volume":"48","author":"Bouffi","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2016.03.004_bib0435","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.biocel.2008.01.007","article-title":"Mesenchymal stem cells: a promising candidate in regenerative medicine","volume":"40","author":"Chen","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0440","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.exphem.2008.03.006","article-title":"Immunosuppression by mesenchymal stromal cells: from culture to clinic","volume":"36","author":"Jones","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0445","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/scrt337","article-title":"Whole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells\u2014a rheumatoid arthritis mouse model","volume":"4","author":"Markides","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2016.03.004_bib0450","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mri.2010.07.015","article-title":"Micrometer-sized iron oxide particle labeling of mesenchymal stem cells for magnetic resonance imaging-based monitoring of cartilage tissue engineering","volume":"29","author":"Saldanha","year":"2011","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.biopha.2016.03.004_bib0455","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2005.11.112","article-title":"In vivo imaging of bone marrow mesenchymal stem cells transplanted into myocardium using magnetic resonance imaging: a novel method to trace the transplanted cells","volume":"114","author":"He","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0460","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.mri.2010.03.047","article-title":"Tracking of transplanted mesenchymal stem cells labeled with fluorescent magnetic nanoparticle in liver cirrhosis rat model with 3-T MRI","volume":"28","author":"Kim","year":"2010","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.biopha.2016.03.004_bib0465","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/nbm.1487","article-title":"The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells","volume":"23","author":"Kim","year":"2010","journal-title":"NMR Biomed."},{"key":"10.1016\/j.biopha.2016.03.004_bib0470","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/nnm.13.217","article-title":"Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis","volume":"9","author":"Duan","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2016.03.004_bib0475","doi-asserted-by":"crossref","unstructured":"X. Huang, Jain PK, El-Sayed IH, El-Sayed MA. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. (2007).","DOI":"10.2217\/17435889.2.5.681"},{"key":"10.1016\/j.biopha.2016.03.004_bib0480","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nnano.2009.235","article-title":"Diagnosing lung cancer in exhaled breath using gold nanoparticles","volume":"4","author":"Peng","year":"2009","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0485","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1021\/ja711298b","article-title":"A one-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering","volume":"130","author":"Liu","year":"2008","journal-title":"J. Amer. Chem. Soc."},{"key":"10.1016\/j.biopha.2016.03.004_bib0490","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1021\/ja057254a","article-title":"Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods","volume":"128","author":"Huang","year":"2006","journal-title":"J. Amer. Chem. Soc."},{"key":"10.1016\/j.biopha.2016.03.004_bib0495","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1158\/1078-0432.CCR-04-2482","article-title":"Antiangiogenic properties of gold nanoparticles","volume":"11","author":"Mukherjee","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2016.03.004_bib0500","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10787-007-0017-6","article-title":"Colloidal metallic gold is not bio-inert","volume":"16","author":"Brown","year":"2008","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2016.03.004_bib0505","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.niox.2010.06.005","article-title":"Gold nanoparticles attenuate LPS-induced NO. production through the inhibition of NF-\u03baB and IFN-\u03b2\/STAT1 pathways in RAW264. 7 cells","volume":"23","author":"Ma","year":"2010","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.biopha.2016.03.004_bib0510","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jinorgbio.2014.09.013","article-title":"An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase","volume":"142","author":"James","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2016.03.004_bib0515","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/nn500685h","article-title":"Hyaluronate\u2014Gold Nanoparticle\/Tocilizumab complex for the treatment of rheumatoid arthritis","volume":"8","author":"Lee","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2016.03.004_bib0520","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2011.09.069","article-title":"Impact of albumin on drug delivery\u2014New applications on the horizon","volume":"157","author":"Elsadek","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2016.03.004_bib0525","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III. trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0530","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.addr.2007.08.044","article-title":"Protein nanoparticles as drug carriers in clinical medicine","volume":"60","author":"Hawkins","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2016.03.004_bib0535","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1517\/17425247.2010.498474","article-title":"Native albumin for targeted drug delivery","volume":"7","author":"Neumann","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2016.03.004_bib0540","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/ard.2003.013748","article-title":"Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo","volume":"63","author":"Fiehn","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2016.03.004_bib0545","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/2230-973X.106981","article-title":"Formulation strategies for drug delivery of tacrolimus: an overview","volume":"2","author":"Patel","year":"2012","journal-title":"Int. J. Pharm. Invest."},{"key":"10.1016\/j.biopha.2016.03.004_bib0550","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijpharm.2015.12.004","article-title":"Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues","volume":"497","author":"Byeon","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2016.03.004_bib0555","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1349-7006.2011.01941.x","article-title":"Nanomedicine in cancer therapy: innovative trends and prospects","volume":"102","author":"Blanco","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2016.03.004_bib0560","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/art.21827","article-title":"Formatted anti?tumor necrosis factor \u03b1 VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen\u2010induced arthritis","volume":"54","author":"Coppieters","year":"2006","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.biopha.2016.03.004_bib0565","first-page":"2","article-title":"Albumin as a delivery carrier for rheumatoid arthritis","volume":"4","author":"Ren","year":"2013","journal-title":"J. Nanomed. Nanotechol."},{"key":"10.1016\/j.biopha.2016.03.004_bib0570","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1472-6750-12-68","article-title":"Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion","volume":"12","author":"Liu","year":"2012","journal-title":"BMC Biotechnol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216300762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216300762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:00:07Z","timestamp":1760094007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216300762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":114,"alternative-id":["S0753332216300762"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.03.004","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of nanoparticle technology in rheumatoid arthritis treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}